Expression of Target in Endometriotic Lesions

Sponsor
Beijing Tsinghua Chang Gung Hospital
Study ID
NCT07693283
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Retrospective molecular expression analysis in endometriosis tissue specimens — OTHER
    This study involves no prospective interventional measures for participants.

Study Details

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.

Key Dates

First listed
Jul 9, 2026
Start date
Apr 13, 2026
Status verified
Apr 2026
Primary completion
Sep 30, 2026
Completion
Feb 12, 2027

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: patients with endometriosis

Primary Outcome Measure

Expression levels of molecular in endometriotic lesions and adjacent normal tissue [ Time Frame: 6 months ]

Central Contacts

Find similar trials

Nationwide
Endometriosis trialsWomen's health trialsFertility trials

Related Studies